# State Street SPDR MSCI World Health Care UCITS ETF Accum.Ptg. USD (HEAW)

**Page:** https://fundology.uk/fund/heaw · ISIN IE00BYTRRB94

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 13/11/2026, HEAW (State Street SPDR MSCI World Health Care UCITS ETF Accum.Ptg. USD, ISIN IE00BYTRRB94) closed at £59.87 on the London Stock Exchange. Its ongoing charge is 0.30% a year (about £30 on £10,000). Over the five years to 13/11/2026 its total return was +38.7%, or +8.3% after UK CPIH inflation.

## Summary

State Street SPDR MSCI World Health Care UCITS ETF Accum.Ptg. USD is an exchange-traded fund (ETF) from SPDR, launched in 2016. It tracks the MSCI World Health Care 35/20 Capped Index - Benchmark TR Net — about 1,300 large and medium-sized companies in 23 developed countries, around 70% of it in the US. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.3% a year — about £30 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Latest close: **£59.87** (13/11/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | HEAW |
| ISIN | IE00BYTRRB94 |
| Also listed as | WHEA (London Stock Exchange, US dollars), SPFS (Xetra, euros) |
| Category | Healthcare |
| Type | ETF |
| Provider | SPDR |
| Tracks | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net |
| Income | Accumulating |
| Ongoing charge | 0.30% a year (£30 per £10,000) |
| Fund size | £619m |
| Launched | 2016 |
| Domicile | Ireland |
| UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 29/04/2016 |

## Past returns (periods to 13/11/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +17.86% | +13.68% | income reinvested |
| 3 years | +36.94% | +23.72% | income reinvested |
| 5 years | +38.69% | +8.25% | income reinvested |

Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of State Street SPDR MSCI World Health Care UCITS ETF Accum.Ptg. USD in pounds (price, with income reinvested in the fund): 2023 −2.0%, 2024 +4.1%, 2025 +5.2%; 2026 to 13/11/2026 +19.4%. Returns of State Street SPDR MSCI World Health Care UCITS ETF Accum.Ptg. USD in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +13.9%; to 30/09/2025: −4.5%; to 30/09/2024: +9.7%; to 30/09/2023: 0.0%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2023 | -2.0% | -6.0% | Price |
| 2024 | +4.1% | +0.6% | Price |
| 2025 | +5.2% | +1.6% | Price |
| 2026 to 13/11/2026 | +19.4% | +15.6% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 16.40% | -10.56% |
| 3 years | 14.18% | -18.10% |

## Largest fall

Volatility of State Street SPDR MSCI World Health Care UCITS ETF Accum.Ptg. USD in pounds, annualised from weekly returns to 13/11/2026: 16.4% over 1 year, 14.2% over 3 years. Largest fall in the price of State Street SPDR MSCI World Health Care UCITS ETF Accum.Ptg. USD since April 2022, in pounds: −18.1% from 30/08/2024 to 23/05/2025. The lowest 12-month return of State Street SPDR MSCI World Health Care UCITS ETF Accum.Ptg. USD in pounds (price, with income reinvested in the fund) since April 2022 was −16.4% (12 months to 08/08/2025); the highest was +23.3% (12 months to 07/08/2026). On 13/11/2026 the price of State Street SPDR MSCI World Health Care UCITS ETF Accum.Ptg. USD was at its highest weekly close since April 2022, in pounds.

## Charges compared with similar funds

Ongoing charge of State Street SPDR MSCI World Health Care UCITS ETF Accum.Ptg. USD 0.30% a year. Compared on 14/11/2026, 15 of the 28 other healthcare funds charge more, 2 the same and 11 less (share classes counted once).

## Charges & eligibility

- Ongoing charges figure (OCF): **0.30%** per year (as of 13/11/2026)
- Stocks and shares ISA eligible: usually (check with your platform)
- SIPP eligible: usually (check with your provider)
- ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify.

## What it holds

As of 05/11/2026, HEAW holds 109 positions, according to its published holdings. The largest is Eli Lilly at 11.91% of the fund; the ten largest make up 48.2%.

### Top holdings

Largest positions (as of 05/11/2026), as a percentage of the whole fund:

| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | Eli Lilly | [LLY](https://fundology.uk/stock/LLY) | 11.91% |
| 2 | Johnson & Johnson | [JNJ](https://fundology.uk/stock/JNJ) | 7.15% |
| 3 | AbbVie | [ABBV](https://fundology.uk/stock/ABBV) | 5.55% |
| 4 | Merck | [MRK](https://fundology.uk/stock/MRK) | 3.96% |
| 5 | UnitedHealth Group | [UNH](https://fundology.uk/stock/UNH) | 3.92% |
| 6 | Roche | [RO](https://fundology.uk/stock/RO) | 3.84% |
| 7 | Novartis | [NOVN](https://fundology.uk/stock/NOVN) | 3.29% |
| 8 | AstraZeneca | [AZN](https://fundology.uk/stock/AZN) | 3.12% |
| 9 | Thermo Fisher Scientific | [TMO](https://fundology.uk/stock/TMO) | 2.75% |
| 10 | Amgen | [AMGN](https://fundology.uk/stock/AMGN) | 2.71% |

## Where it invests

Shares of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.

### By country

Added up from the fund’s published holdings, as of 05/11/2026.

| Country | Weight |
|---|---|
| United States | 73.3% |
| Switzerland | 9.5% |
| United Kingdom | 4.8% |
| Japan | 3.4% |
| France | 2.2% |
| Denmark | 1.9% |
| Germany | 1.7% |
| Belgium | 1.1% |
| Other countries | 2.2% |

All 109 holdings: https://fundology.uk/fund/heaw/holdings

## Questions people ask

**What is the ongoing charge of HEAW?**

The ongoing charge of HEAW is 0.30% a year — about £30 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of State Street SPDR MSCI World Health Care UCITS ETF Accum.Ptg. USD 0.30% a year. Compared on 14/11/2026, 15 of the 28 other healthcare funds charge more, 2 the same and 11 less (share classes counted once).

**What does HEAW track?**

HEAW tracks the MSCI World Health Care 35/20 Capped Index - Benchmark TR Net — about 1,300 large and medium-sized companies in 23 developed countries, around 70% of it in the US.

**Is HEAW accumulating or distributing?**

HEAW is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

**What is the ISIN of HEAW?**

The ISIN of HEAW is IE00BYTRRB94. An ISIN identifies one exact share class of a fund; HEAW is its ticker on the London Stock Exchange. The same share class is also listed as WHEA (London Stock Exchange, US dollars) and SPFS (Xetra, euros).

**What does HEAW hold?**

As of 05/11/2026, HEAW holds 109 positions, according to its published holdings. The largest is Eli Lilly at 11.91% of the fund; the ten largest make up 48.2%. Its ten largest holdings are Eli Lilly (11.91%), Johnson & Johnson (7.15%), AbbVie (5.55%), Merck (3.96%), UnitedHealth Group (3.92%), Roche (3.84%), Novartis (3.29%), AstraZeneca (3.12%), Thermo Fisher Scientific (2.75%) and Amgen (2.71%).

**What were HEAW’s returns in each of the last five years?**

Calendar-year returns of HEAW in pounds (price, with income reinvested in the fund): 2023 −2.0%, 2024 +4.1%, 2025 +5.2%; 2026 to 13/11/2026 +19.4%. Past performance is not a guide to future returns.

**How has HEAW done after inflation?**

Over the five years to 13/11/2026 HEAW’s total return was +38.7%, or +8.3% after UK CPIH inflation. Past performance is not a guide to future returns.

## Fund documents

- [Fund page at State Street Global Advisors](https://www.ssga.com/uk/en_gb/intermediary/etfs/state-street-spdr-msci-world-health-care-ucits-etf-whea-na)
- [Key investor information document (KIID)](https://www.ssga.com/library-content/kiids?isin=IE00BYTRRB94&documentType=kiid&country=uk&language=en_gb&ticker=whea-na)
- [Factsheet](https://www.ssga.com/library-content/products/factsheets/etfs/emea/factsheet-emea-en_gb-whea-na.pdf)
- Links checked 12/10/2026.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.